These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19067215)

  • 1. Mice transgenic with SV40-late-promoter-driven Polyomavirus Middle T oncogene exclusively develop hemangiomas.
    Xu Q; Chen W; Wang Z; Zheng J; Zhang Z
    Transgenic Res; 2009 Jun; 18(3):399-406. PubMed ID: 19067215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development.
    Sausville J; Molinolo AA; Cheng X; Frampton J; Takebe N; Gutkind JS; Feldman RA
    Clin Cancer Res; 2008 Jun; 14(12):3948-55. PubMed ID: 18559617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The formation of transgenic mice with hemangiomas].
    Xu Q; Zhang ZY; Chen WT; Yang WJ; Wang ZG; Wang L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Sep; 38(5):355-7. PubMed ID: 14680584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endothelial cells expressing polyoma middle T induce tumors.
    Primo L; Roca C; Ferrandi C; Lanfrancone L; Bussolino F
    Oncogene; 2000 Jul; 19(32):3632-41. PubMed ID: 10951569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.
    Suda Y; Aizawa S; Hirai S; Inoue T; Furuta Y; Suzuki M; Hirohashi S; Ikawa Y
    EMBO J; 1987 Dec; 6(13):4055-65. PubMed ID: 2832150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK.
    Xie F; Bao X; Yu J; Chen W; Wang L; Zhang Z; Xu Q
    Oncotarget; 2015 Sep; 6(28):25660-76. PubMed ID: 26308070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases.
    Kiefer F; Anhauser I; Soriano P; Aguzzi A; Courtneidge SA; Wagner EF
    Curr Biol; 1994 Feb; 4(2):100-9. PubMed ID: 7953508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guide to techniques in creating transgenic mouse models using SV40 T antigen.
    Maroulakou IG; Muise-Helmericks RC
    Methods Mol Biol; 2001; 165():269-86. PubMed ID: 11217393
    [No Abstract]   [Full Text] [Related]  

  • 9. Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene.
    Bautch VL; Toda S; Hassell JA; Hanahan D
    Cell; 1987 Nov; 51(4):529-37. PubMed ID: 2445489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment.
    Williams RL; Risau W; Zerwes HG; Drexler H; Aguzzi A; Wagner EF
    Cell; 1989 Jun; 57(6):1053-63. PubMed ID: 2736622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.
    Sola C; Tronik D; Dreyfus M; Babinet C; Rougeon F
    Oncogene Res; 1989; 5(2):149-53. PubMed ID: 2558335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen.
    Marcus DM; Lasudry JG; Carpenter JL; Windle J; Howes KA; al-Ubaidi MR; Baehr W; Overbeek PA; Font RL; Albert DM
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):392-6. PubMed ID: 8603844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel transgenic mice model for venous malformation.
    Wang YA; Zheng JW; Fei ZL; Jiang XQ; Wang ZG; Fei J; Zhang ZY
    Transgenic Res; 2009 Apr; 18(2):193-201. PubMed ID: 18853270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue specificity of oncogene action: endothelial cell tumours in polyoma middle T transgenic mice.
    Bautch VL; Toda S; Hassell JA; Hanahan D
    IARC Sci Publ; 1989; (96):255-66. PubMed ID: 2807487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TEF-1-independent mechanism for activation of the simian virus 40 (SV40) late promoter by mutant SV40 large T antigens.
    Casaz P; Rice PW; Cole CN; Hansen U
    J Virol; 1995 Jun; 69(6):3501-9. PubMed ID: 7745697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multistep hepatocarcinogenesis in transgenic mice harboring SV40 T-antigen gene.
    Kitagawa T; Hino O; Lee GH; Li H; Liu J; Nomura K; Ohtake K; Furuta Y; Aizawa S
    Princess Takamatsu Symp; 1991; 22():349-60. PubMed ID: 1668891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice.
    Moore M; Teresky AK; Levine AJ; Seiberg M
    J Virol; 1992 Feb; 66(2):641-9. PubMed ID: 1370552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.
    Theuring F; Götz W; Balling R; Korf HW; Schulze F; Herken R; Gruss P
    Oncogene; 1990 Feb; 5(2):225-32. PubMed ID: 2157185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences.
    March KL; Sandusky G; Fan L
    Oncogene; 1999 Jun; 18(25):3773-82. PubMed ID: 10391686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for the simian virus 40 small tumor antigen in tumorigenesis in transgenic mice.
    Choi YW; Lee IC; Ross SR
    Mol Cell Biol; 1988 Aug; 8(8):3382-90. PubMed ID: 2850490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.